Discover

XBIT
XBiotech Inc.
2.19
2 x 1.61
2 x 2.76
bid
ask
+
0.03
1.39%
2 @ 07:30 PM
2.19 +0.00 (0.00%)
Ytd-8.37%
1y-20.65%
2.16
day range
2.22
2.12
52 week range
2.94
Open2.20Prev Close2.16Low2.16High2.22Mkt Cap66.77M
Vol66.09KAvg Vol41.22KEPS-1.48P/EN/AForward P/E34.62
Beta0.85Short Ratio15.03Inst. Own16.19%DividendN/ADiv YieldN/A
Ex Div Date07-15Earning08-1550-d Avg2.26200-d Avg2.381yr Est13.00
Income Statement
Operating Expenses6.15M
Research and Development Expense5.30M
Selling, General and Administrative Expense850.00K
Operating Income-6.15M
Income Tax Expense46.00K
Net Income-6.73M
Net Income Common Stock-6.73M
Net Income Common Stock (USD)-6.73M
Consolidated Income-6.73M
Earnings per Basic Share-0.22
Earnings per Basic Share (USD)-0.22
Earnings per Diluted Share-0.22
Earning Before Interest & Taxes (EBIT)-6.68M
Earning Before Interest & Taxes (USD)-6.68M
Weighted Average Shares30.49M
Weighted Average Shares Diluted30.49M
Balance Sheet
Cash and Equivalents109.53M
Cash and Equivalents (USD)109.53M
Current Assets111.16M
Property, Plant & Equipment Net22.49M
Total Assets133.65M
Current Liabilities3.35M
Total Liabilities5.19M
Accumulated Retained Earnings (Deficit)-148.61M
Shareholders Equity128.46M
Shareholders Equity (USD)128.46M
Assets Non-Current22.49M
Liabilities Non-Current1.84M
Trade and Non-Trade Payables1.11M
Tax Assets14.00K
Tax Liabilities1.84M
Cash Flow
Depreciation, Amortization & Accretion302.00K
Net Cash Flow / Change in Cash & Cash Equivalents-5.93M
Capital Expenditure-4.00K
Net Cash Flow from Investing-4.00K
Net Cash Flow from Operations-4.51M
Effect of Exchange Rate Changes on Cash -1.41M
Share Based Compensation172.00K